Quality certification programs for cancer care face persistent scrutiny over whether bureaucratic credentialing translates into measurable patient benefits. New evidence from nearly 60,000 rectal cancer cases suggests that formal accreditation does improve surgical precision in ways that could extend survival. The analysis tracked circumferential resection margin rates—a critical measure of surgical quality where positive margins indicate cancer cells remain at the tissue edge after tumor removal. Accredited hospitals achieved an 8.7% relative reduction in positive margin rates compared to non-accredited centers, dropping from 14.9% to 12.0% over the study period. This represented a 1.1 percentage point improvement beyond what occurred at non-accredited facilities. Accredited centers also demonstrated superior pre-surgical assessment protocols, with carcinoembryonic antigen testing rates rising 4.2 percentage points higher than at standard hospitals. The National Accreditation Program for Rectal Cancer, launched in 2017, requires multidisciplinary tumor boards, specialized surgical volume thresholds, and standardized care pathways. Only 57 of 800 hospitals achieved certification during the study window, suggesting rigorous standards. For patients facing rectal cancer surgery, these findings support seeking care at accredited centers when feasible. Positive surgical margins correlate with local recurrence and reduced survival, making surgical precision paramount. However, the observational design cannot definitively establish causation, and accredited hospitals may attract more skilled teams independent of certification requirements. The modest absolute improvement also raises questions about cost-effectiveness of intensive credentialing processes across cancer care.